PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23408783-11	2013	In addition, RSG, BEZ and the combination of RSG and BEZ also inhibited MCP-1 secretion.	Bezafibrate	18-21	C-C motif chemokine ligand 2	Homo sapiens	72-77	
12640339-11	2003	In addition, the percentage increment of MCP-1 was higher in patients treated with gemfibrozil than in patients who received bezafibrate.	Bezafibrate	125-136	C-C motif chemokine ligand 2	Homo sapiens	41-46	
28866026-8	2017	In HRMECs, the expression levels of tumor necrosis factor (TNF)-alpha-induced monocyte chemoattractant protein (MCP)-1, intercellular adhesion molecule (ICAM)-1, and vascular cell adhesion molecule (VCAM)-1 were significantly suppressed by bezafibrate in a dose-dependent manner.	Bezafibrate	240-251	C-C motif chemokine ligand 2	Homo sapiens	78-118	
23408783-11	2013	In addition, RSG, BEZ and the combination of RSG and BEZ also inhibited MCP-1 secretion.	Bezafibrate	53-56	C-C motif chemokine ligand 2	Homo sapiens	72-77	
21119093-5	2011	Bezafibrate treatment normalized monocyte release of MCP-1, interleukin-6, TNF-alpha, and interleukin-1beta and also normalized plasma hsCRP levels in mixed dyslipidemic subjects, whereas in IFG individuals the drug reduced only MCP-1 and interleukin-6 release.	Bezafibrate	0-11	C-C motif chemokine ligand 2	Homo sapiens	53-58	
21119093-5	2011	Bezafibrate treatment normalized monocyte release of MCP-1, interleukin-6, TNF-alpha, and interleukin-1beta and also normalized plasma hsCRP levels in mixed dyslipidemic subjects, whereas in IFG individuals the drug reduced only MCP-1 and interleukin-6 release.	Bezafibrate	0-11	C-C motif chemokine ligand 2	Homo sapiens	229-234